Question Everything. See who's reporting it.

Walmart Expands into GLP-1 Drug Access

Source: CNBC

The story in brief

Walmart is expanding its role in the prescription market by offering GLP-1 weight-loss drugs directly to consumers through programs like LillyDirect, which charges $299 to $449 monthly. The move, driven by direct-to-consumer access, positions Walmart to compete with CVS and Walgreens, while also drawing Amazon into the healthcare space. Independent pharmacies face challenges as major retailers gain access to these drugs.

NEWXFree on Android and iPhone. Open in NEWX